Basis of Presentation and Accounting Policies (Details) (USD $)	1 Months Ended		6 Months Ended		79 Months Ended
	Jun. 30, 2012	May 31, 2012	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	May 09, 2012	Dec. 31, 2011	Nov. 30, 2011	Dec. 31, 2010	Jul. 14, 2008 Pawfect
Percentage of common stock acquired in Synergy-DE										100.00%
Reverse stock split ratio on authorized, issued and outstanding shares of common stock								0.5
Accumulated deficit	$ 87,190,110		$ 87,190,110		$ 87,190,110		$ 69,609,018
Net cash used in operating activities			(13,814,900)	(6,980,317)	(56,898,903)
Cash and cash equivalents on hand	27,426,900		27,426,900	503,744	27,426,900		13,244,883		1,707,516
Available-for-sale securities	20,160,576		20,160,576		20,160,576
Working capital	40,065,845		40,065,845		40,065,845		11,561,286
Number of shares of common stock closed under an underwritten public offering		10,000,000
Common stock price per share for public offering and over-allotment						$ 4.50
Proceeds from sale of common stock	6,750,000	45,000,000	51,750,000	5,461,242	112,293,164
Underwriting discounts and commissions and other offering expenses	$ 405,000	$ 2,952,930	$ 3,357,930	$ 395,620	$ 6,307,533
Period during which underwriters can purchase additional shares to cover an over-allotment option		45 days
Additional shares of common stock purchased by underwriters to cover over-allotment		1,500,000